MELPHALAN

MELPHALAN was reported 25291 times

MELPHALAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGOMYELITIS HERPES 15 0.4688
1 PROTOTHECOSIS 37 0.3936
2 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 15 0.2542
3 CHOROIDAL INFARCTION 28 0.2333
4 CHORIORETINAL ATROPHY 48 0.2319
5 PRE-ENGRAFTMENT IMMUNE REACTION 18 0.2250
6 JUVENILE MELANOMA BENIGN 14 0.2121
7 ENGRAFTMENT SYNDROME 125 0.2115
8 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 21 0.2059
9 CLONAL HAEMATOPOIESIS 15 0.1948
10 MALIGNANT TRANSFORMATION 85 0.1893
11 IRIS ATROPHY 39 0.1884
12 NEUROBLASTOMA RECURRENT 34 0.1675
13 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 20 0.1639
14 BLOOD STEM CELL TRANSPLANT FAILURE 35 0.1628
15 POEMS SYNDROME 17 0.1619
16 ADENOVIRUS REACTIVATION 22 0.1528
17 IDIOPATHIC PNEUMONIA SYNDROME 45 0.1510
18 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 28 0.1474
19 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 13 0.1461
20 ADENOVIRAL HEPATITIS 34 0.1447
21 ENGRAFT FAILURE 40 0.1394
22 PNEUMONIA ADENOVIRAL 27 0.1364
23 LIGHT CHAIN DISEASE 18 0.1241
24 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 172 0.1217
25 HUMAN HERPESVIRUS 6 ENCEPHALITIS 33 0.1162
26 GASTROENTERITIS ADENOVIRUS 18 0.1146
27 ADENOVIRUS INFECTION 327 0.1126
28 HEPATIC INFECTION FUNGAL 13 0.1083
29 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 38 0.1083
30 RETINAL DEPIGMENTATION 33 0.1078
31 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 298 0.1077
32 VENOOCCLUSIVE LIVER DISEASE 525 0.1062
33 ADENOVIRAL HAEMORRHAGIC CYSTITIS 22 0.1058
34 ACUTE GRAFT VERSUS HOST DISEASE 478 0.1043
35 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 95 0.1026
36 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 135 0.1025
37 ATROPHY OF GLOBE 13 0.1016
38 ASPIRATION BONE MARROW 13 0.0977
39 CYSTITIS VIRAL 37 0.0966
40 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 68 0.0946
41 VIRAL HAEMORRHAGIC CYSTITIS 67 0.0941
42 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 198 0.0930
43 CHORIORETINAL DISORDER 18 0.0914
44 VENOOCCLUSIVE DISEASE 221 0.0882
45 GRAFT VERSUS HOST DISEASE IN SKIN 194 0.0880
46 MANTLE CELL LYMPHOMA RECURRENT 38 0.0874
47 AUTOIMMUNE NEUTROPENIA 25 0.0865
48 CHRONIC GRAFT VERSUS HOST DISEASE 306 0.0847
49 PLASMACYTOSIS 16 0.0838
50 CHROMOSOMAL DELETION 13 0.0818
51 PLASMA CELL MYELOMA REFRACTORY 109 0.0815
52 BRONCHIOLITIS OBLITERANS SYNDROME 14 0.0800
53 HUMAN HERPESVIRUS 6 INFECTION 147 0.0777
54 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 19 0.0776
55 EPSTEIN-BARR VIRAEMIA 84 0.0757
56 B-CELL TYPE ACUTE LEUKAEMIA 54 0.0736
57 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 23 0.0735
58 CENTRAL HYPOTHYROIDISM 23 0.0695
59 NASAL ABSCESS 16 0.0693
60 VIRAEMIA 95 0.0685
61 B-CELL LYMPHOMA RECURRENT 36 0.0663
62 BONE DEBRIDEMENT 32 0.0663
63 OSTEOSARCOMA 25 0.0649
64 CYTOMEGALOVIRUS INFECTION REACTIVATION 286 0.0647
65 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 13 0.0640
66 UREAPLASMA INFECTION 26 0.0637
67 POLYCHROMASIA 19 0.0633
68 PLASMA CELL MYELOMA RECURRENT 204 0.0627
69 B PRECURSOR TYPE ACUTE LEUKAEMIA 24 0.0619
70 GRAFT VERSUS HOST DISEASE 444 0.0617
71 PLASMA CELL LEUKAEMIA 37 0.0617
72 APOPTOSIS 19 0.0615
73 BONE MARROW TRANSPLANT REJECTION 13 0.0591
74 CEREBRAL TOXOPLASMOSIS 55 0.0589
75 JC VIRUS INFECTION 93 0.0581
76 MORGANELLA INFECTION 17 0.0580
77 WOUND DEBRIDEMENT 24 0.0574
78 GRAFT VERSUS HOST DISEASE IN LIVER 40 0.0559
79 GASTROINTESTINAL FUNGAL INFECTION 28 0.0544
80 MONOCLONAL IMMUNOGLOBULIN INCREASED 15 0.0524
81 PRIMARY SEQUESTRUM 47 0.0519
82 COMPLICATIONS OF BONE MARROW TRANSPLANT 18 0.0499
83 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 18 0.0495
84 STEM CELL TRANSPLANT 121 0.0484
85 BK VIRUS INFECTION 159 0.0471
86 MYELODYSPLASTIC SYNDROME 660 0.0456
87 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 229 0.0449
88 IRIS ADHESIONS 23 0.0448
89 OSTEOLYSIS 90 0.0440
90 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 37 0.0439
91 MUCOSAL INFLAMMATION 1148 0.0438
92 PLASMACYTOMA 81 0.0435
93 THROMBOTIC MICROANGIOPATHY 424 0.0435
94 NEUTROPENIC COLITIS 89 0.0430
95 TRANSPLANTATION COMPLICATION 18 0.0429
96 TRANSPLANT FAILURE 104 0.0424
97 KLEBSIELLA BACTERAEMIA 40 0.0421
98 DEVICE RELATED BACTERAEMIA 13 0.0419
99 RETINAL PIGMENT EPITHELIOPATHY 18 0.0417
100 ENTEROCOCCAL BACTERAEMIA 44 0.0415
101 GASTROINTESTINAL MUCOSAL DISORDER 27 0.0412
102 HUMAN HERPESVIRUS 8 INFECTION 25 0.0411
103 ACUTE LYMPHOCYTIC LEUKAEMIA 116 0.0409
104 GROWTH FAILURE 14 0.0407
105 GRAFT VERSUS HOST DISEASE IN LUNG 19 0.0397
106 HUMAN POLYOMAVIRUS INFECTION 21 0.0395
107 SEQUESTRECTOMY 26 0.0390
108 METASTATIC LYMPHOMA 15 0.0384
109 ASEPTIC NECROSIS BONE 30 0.0384
110 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 83 0.0376
111 PARAINFLUENZAE VIRUS INFECTION 57 0.0374
112 METAPNEUMOVIRUS INFECTION 29 0.0370
113 CYSTITIS HAEMORRHAGIC 148 0.0367
114 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 24 0.0366
115 METASTASES TO BONE MARROW 18 0.0360
116 ENTEROCOCCAL SEPSIS 29 0.0358
117 SYSTEMIC MYCOSIS 41 0.0351
118 PNEUMONIA CYTOMEGALOVIRAL 68 0.0350
119 LENTICULAR OPACITIES 15 0.0343
120 PULMONARY VENO-OCCLUSIVE DISEASE 24 0.0343
121 FUSARIUM INFECTION 24 0.0343
122 INFECTION REACTIVATION 39 0.0341
123 SCEDOSPORIUM INFECTION 24 0.0340
124 EPSTEIN-BARR VIRUS INFECTION 212 0.0339
125 VARICELLA ZOSTER VIRUS INFECTION 70 0.0337
126 SINUS POLYP 19 0.0329
127 PLASMA CELL MYELOMA 1286 0.0329
128 APLASIA 63 0.0321
129 SECOND PRIMARY MALIGNANCY 265 0.0318
130 PREMATURE MENOPAUSE 29 0.0314
131 ACTINOMYCOSIS 30 0.0313
132 ROTAVIRUS INFECTION 18 0.0312
133 CYTOMEGALOVIRUS VIRAEMIA 138 0.0310
134 ACUTE MYELOID LEUKAEMIA 483 0.0310
135 ENCEPHALITIS VIRAL 37 0.0304
136 BACTERIAL SEPSIS 99 0.0304
137 MONOCLONAL GAMMOPATHY 19 0.0303
138 ENCEPHALITIS CYTOMEGALOVIRUS 13 0.0297
139 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 52 0.0294
140 MINIMAL RESIDUAL DISEASE 14 0.0290
141 CANDIDA SEPSIS 26 0.0290
142 VITREOUS HAEMORRHAGE 80 0.0289
143 PNEUMOCOCCAL SEPSIS 19 0.0289
144 CYTOMEGALOVIRUS TEST POSITIVE 51 0.0286
145 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 13 0.0279
146 KLEBSIELLA SEPSIS 31 0.0275
147 AORTIC CALCIFICATION 16 0.0275
148 SYSTEMIC CANDIDA 69 0.0275
149 CHRONIC MYELOMONOCYTIC LEUKAEMIA 18 0.0273
150 CYTOMEGALOVIRUS INFECTION 448 0.0269
151 CRYPTOSPORIDIOSIS INFECTION 14 0.0267
152 FUNGAEMIA 42 0.0267
153 AMYLOIDOSIS 46 0.0267
154 HEPATITIS E 42 0.0266
155 TOXOPLASMOSIS 28 0.0259
156 RETINAL TOXICITY 26 0.0252
157 OBLITERATIVE BRONCHIOLITIS 33 0.0251
158 ABDOMINAL COMPARTMENT SYNDROME 16 0.0251
159 MONOCLONAL IMMUNOGLOBULIN PRESENT 19 0.0250
160 FOLLICULAR LYMPHOMA 22 0.0250
161 PULMONARY MYCOSIS 19 0.0244
162 ESCHERICHIA BACTERAEMIA 57 0.0242
163 STAPHYLOCOCCAL BACTERAEMIA 105 0.0241
164 CYTOMEGALOVIRUS CHORIORETINITIS 47 0.0241
165 HYPOGAMMAGLOBULINAEMIA 157 0.0239
166 HERPES ZOSTER DISSEMINATED 19 0.0237
167 MANTLE CELL LYMPHOMA 36 0.0236
168 ENTEROVIRUS INFECTION 20 0.0231
169 VERTEBRAL FORAMINAL STENOSIS 19 0.0231
170 BONE SWELLING 22 0.0227
171 ENTEROCOCCAL INFECTION 109 0.0225
172 BONE LESION 81 0.0224
173 STREPTOCOCCAL BACTERAEMIA 24 0.0221
174 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 181 0.0219
175 PNEUMONIA FUNGAL 86 0.0218
176 HEPATITIS B REACTIVATION 69 0.0217
177 OSTEOSCLEROSIS 34 0.0216
178 STENOTROPHOMONAS INFECTION 29 0.0214
179 PARVOVIRUS B19 INFECTION 19 0.0212
180 CYTOPENIA 258 0.0211
181 POLYNEUROPATHY 251 0.0209
182 MUCOSAL EROSION 19 0.0209
183 BACTERAEMIA 244 0.0205
184 ENDOCARDITIS BACTERIAL 16 0.0203
185 VITH NERVE PARALYSIS 23 0.0202
186 ACUTE MYELOID LEUKAEMIA RECURRENT 43 0.0200
187 SINUSITIS FUNGAL 16 0.0200
188 INTERVERTEBRAL DISC SPACE NARROWING 16 0.0199
189 BRONCHOPULMONARY ASPERGILLOSIS 153 0.0197
190 ASPERGILLUS INFECTION 129 0.0196
191 CYTOMEGALOVIRUS ENTEROCOLITIS 15 0.0195
192 STAPHYLOCOCCAL SEPSIS 96 0.0194
193 VISCERAL LEISHMANIASIS 14 0.0194
194 DIARRHOEA INFECTIOUS 15 0.0190
195 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 142 0.0189
196 FEBRILE NEUTROPENIA 1255 0.0189
197 IIIRD NERVE PARALYSIS 15 0.0185
198 FUNGAL OESOPHAGITIS 13 0.0184
199 HAEMATOTOXICITY 173 0.0182
200 EJECTION FRACTION ABNORMAL 22 0.0179
201 ESCHERICHIA SEPSIS 52 0.0179
202 DISTURBANCE IN SOCIAL BEHAVIOUR 42 0.0178
203 BONE MARROW TOXICITY 21 0.0177
204 CYTOGENETIC ABNORMALITY 20 0.0177
205 ADENOCARCINOMA OF COLON 33 0.0176
206 PERIPHERAL SENSORIMOTOR NEUROPATHY 22 0.0175
207 ABSCESS JAW 18 0.0173
208 ADENOCARCINOMA GASTRIC 16 0.0172
209 THERAPY PARTIAL RESPONDER 268 0.0172
210 GASTROINTESTINAL INFLAMMATION 133 0.0170
211 CYTOMEGALOVIRUS COLITIS 39 0.0169
212 RETINAL DEGENERATION 22 0.0169
213 VASCULAR CALCIFICATION 18 0.0169
214 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 160 0.0167
215 CAPILLARY LEAK SYNDROME 34 0.0164
216 HAEMATOLOGICAL INFECTION 40 0.0163
217 EXPOSED BONE IN JAW 35 0.0161
218 POLYOMAVIRUS VIRAEMIA 17 0.0160
219 FEBRILE BONE MARROW APLASIA 68 0.0160
220 PNEUMONIA INFLUENZAL 19 0.0160
221 AUTONOMIC NEUROPATHY 16 0.0158
222 GASTROINTESTINAL WALL THICKENING 22 0.0147
223 DIFFUSE LARGE B-CELL LYMPHOMA 113 0.0147
224 PNEUMONIA STREPTOCOCCAL 16 0.0146
225 ACUTE PROMYELOCYTIC LEUKAEMIA 15 0.0146
226 FEBRILE INFECTION 17 0.0144
227 HYPOPERFUSION 15 0.0143
228 MUCOSAL DISORDER 14 0.0141
229 CLOSTRIDIUM COLITIS 17 0.0140
230 RENAL TUBULAR INJURY 17 0.0140
231 MYCOBACTERIAL INFECTION 24 0.0139
232 RHINOVIRUS INFECTION 54 0.0139
233 GASTROINTESTINAL TOXICITY 66 0.0137
234 CARDIAC AMYLOIDOSIS 15 0.0136
235 LYMPHOPROLIFERATIVE DISORDER 40 0.0136
236 MULTIPLE ORGAN DYSFUNCTION SYNDROME 380 0.0134
237 MENINGITIS BACTERIAL 19 0.0133
238 MUCOUS MEMBRANE DISORDER 18 0.0132
239 PHARYNGEAL INFLAMMATION 16 0.0132
240 PSEUDOMONAL SEPSIS 23 0.0131
241 TRANSITIONAL CELL CARCINOMA 17 0.0131
242 KLEBSIELLA INFECTION 66 0.0130
243 PNEUMONIA PSEUDOMONAL 20 0.0130
244 DEVICE RELATED SEPSIS 26 0.0129
245 PERIPHERAL SENSORY NEUROPATHY 75 0.0128
246 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 33 0.0128
247 NEUTROPENIC SEPSIS 91 0.0127
248 CUTANEOUS T-CELL LYMPHOMA 16 0.0127
249 HYPERAMMONAEMIC ENCEPHALOPATHY 22 0.0126
250 SOFT TISSUE INFECTION 23 0.0126
251 NEUROLOGICAL DECOMPENSATION 29 0.0125
252 HAEMOLYTIC URAEMIC SYNDROME 29 0.0125
253 HISTIOCYTOSIS HAEMATOPHAGIC 37 0.0124
254 APLASTIC ANAEMIA 65 0.0124
255 PULMONARY TOXICITY 88 0.0124
256 OTOTOXICITY 23 0.0124
257 BLOOD CULTURE POSITIVE 37 0.0123
258 AUTOIMMUNE HAEMOLYTIC ANAEMIA 42 0.0122
259 PNEUMONIA PNEUMOCOCCAL 18 0.0121
260 KERATOPATHY 19 0.0120
261 ACINETOBACTER INFECTION 13 0.0119
262 LEUKAEMIA RECURRENT 20 0.0118
263 LUNG INFILTRATION 102 0.0115
264 BLOOD IMMUNOGLOBULIN G INCREASED 14 0.0115
265 NEOPLASM RECURRENCE 39 0.0115
266 ASPERGILLOSIS 15 0.0115
267 MASTICATION DISORDER 35 0.0114
268 KYPHOSIS 20 0.0113
269 GASTROENTERITIS NOROVIRUS 15 0.0113
270 PNEUMATOSIS INTESTINALIS 32 0.0112
271 ACUTE LEUKAEMIA 18 0.0111
272 HEPATITIS B 67 0.0111
273 PULMONARY HAEMORRHAGE 85 0.0109
274 EMBOLISM ARTERIAL 13 0.0108
275 PANCYTOPENIA 598 0.0107
276 GENE MUTATION 21 0.0106
277 LYMPHOPENIA 150 0.0106
278 MYELOPATHY 20 0.0105
279 BONE MARROW FAILURE 214 0.0105
280 CLOSTRIDIUM DIFFICILE COLITIS 111 0.0105
281 ENTEROCOLITIS 60 0.0104
282 KIDNEY FIBROSIS 18 0.0104
283 MULTIPLE MYELOMA 48 0.0103
284 ACUTE RESPIRATORY DISTRESS SYNDROME 182 0.0103
285 VENTRICULAR HYPOKINESIA 33 0.0103
286 ENTERITIS 65 0.0101
287 LICHENOID KERATOSIS 23 0.0101
288 PNEUMOCYSTIS JIROVECII PNEUMONIA 101 0.0100
289 PSEUDOMONAS INFECTION 86 0.0100
290 H1N1 INFLUENZA 14 0.0100
291 MYELITIS TRANSVERSE 14 0.0099
292 SEPTIC SHOCK 426 0.0098
293 NOCARDIOSIS 25 0.0098
294 LEUKOENCEPHALOPATHY 36 0.0097
295 MUCORMYCOSIS 25 0.0096
296 JUGULAR VEIN THROMBOSIS 17 0.0095
297 OSTEITIS 24 0.0095
298 SQUAMOUS CELL CARCINOMA OF SKIN 57 0.0094
299 PARESIS 21 0.0094
300 THROMBOCYTOPENIA 1048 0.0094
301 AORTIC ARTERIOSCLEROSIS 24 0.0093
302 MULTI-ORGAN FAILURE 161 0.0093
303 CARDIOTOXICITY 83 0.0093
304 ACUTE SINUSITIS 16 0.0093
305 NEPHROPATHY TOXIC 104 0.0093
306 ESCHERICHIA INFECTION 76 0.0092
307 OPTIC ATROPHY 15 0.0092
308 TUMOUR LYSIS SYNDROME 80 0.0091
309 NEOPLASM SKIN 14 0.0090
310 HEPATOSPLENOMEGALY 23 0.0090
311 BASAL CELL CARCINOMA 138 0.0088
312 BACTERIAL INFECTION 165 0.0088
313 COMPUTERISED TOMOGRAM ABNORMAL 20 0.0088
314 ENCEPHALITIS 61 0.0088
315 ENTEROCOLITIS HAEMORRHAGIC 13 0.0088
316 TOOTH EXTRACTION 108 0.0087
317 SPONDYLOLISTHESIS 15 0.0086
318 LUNG ADENOCARCINOMA 26 0.0086
319 HEPATIC CYST 29 0.0085
320 RENAL TUBULAR DISORDER 24 0.0085
321 IMMUNE THROMBOCYTOPENIC PURPURA 24 0.0085
322 INVASIVE DUCTAL BREAST CARCINOMA 23 0.0085
323 ATELECTASIS 81 0.0084
324 HERPES SIMPLEX 54 0.0083
325 BRAIN ABSCESS 21 0.0083
326 NEUTROPENIA 1124 0.0083
327 HYPERAMMONAEMIA 41 0.0082
328 PURULENT DISCHARGE 35 0.0082
329 OPPORTUNISTIC INFECTION 15 0.0081
330 GRANULOCYTE COUNT DECREASED 15 0.0081
331 PATHOLOGICAL FRACTURE 41 0.0081
332 ILEUS PARALYTIC 36 0.0081
333 PSEUDOMEMBRANOUS COLITIS 18 0.0081
334 RESPIRATORY SYNCYTIAL VIRUS INFECTION 70 0.0080
335 HYPERURICAEMIA 33 0.0080
336 BONE DISORDER 146 0.0080
337 SMALL INTESTINAL PERFORATION 15 0.0080
338 VENOUS THROMBOSIS 31 0.0079
339 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 21 0.0079
340 LUNG CONSOLIDATION 22 0.0079
341 HYPOREFLEXIA 15 0.0078
342 RETINOPATHY 29 0.0078
343 HYPOALBUMINAEMIA 60 0.0077
344 OSTEONECROSIS 252 0.0077
345 ORAL FUNGAL INFECTION 21 0.0077
346 DEAFNESS NEUROSENSORY 25 0.0076
347 EMBOLISM VENOUS 23 0.0076
348 RENAL CELL CARCINOMA 37 0.0076
349 CYTOKINE RELEASE SYNDROME 150 0.0075
350 RETINAL HAEMORRHAGE 53 0.0074
351 CLOSTRIDIAL INFECTION 25 0.0074
352 NEUROPATHY PERIPHERAL 699 0.0073
353 MYELOSUPPRESSION 264 0.0073
354 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 28 0.0073
355 BONE MARROW DISORDER 22 0.0073
356 SEPSIS 809 0.0072
357 ARTERIAL THROMBOSIS 14 0.0072
358 RADICULOPATHY 19 0.0072
359 ISCHAEMIA 33 0.0072
360 HYPOPHOSPHATAEMIA 53 0.0072
361 DUODENITIS 22 0.0072
362 CANDIDA INFECTION 121 0.0072
363 MYOSITIS 64 0.0071
364 PULMONARY ALVEOLAR HAEMORRHAGE 40 0.0071
365 HEPATITIS FULMINANT 21 0.0071
366 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 35 0.0070
367 OESOPHAGITIS 76 0.0069
368 CHRONIC MYELOID LEUKAEMIA 32 0.0069
369 HYPERCALCAEMIA 85 0.0069
370 AUTONOMIC NERVOUS SYSTEM IMBALANCE 20 0.0068
371 SPINAL OSTEOARTHRITIS 59 0.0067
372 CARDIOMYOPATHY 99 0.0067
373 HYPERBILIRUBINAEMIA 69 0.0067
374 OSTEOMYELITIS 120 0.0066
375 DISEASE PROGRESSION 782 0.0066
376 PNEUMONIA VIRAL 21 0.0066
377 ESCHERICHIA URINARY TRACT INFECTION 28 0.0066
378 VENTRICULAR DYSFUNCTION 17 0.0065
379 HEPATOMEGALY 64 0.0065
380 HYPERVOLAEMIA 32 0.0065
381 NECROSIS 36 0.0065
382 PERICARDIAL EFFUSION 149 0.0064
383 LEFT VENTRICULAR DYSFUNCTION 43 0.0064
384 GASTROINTESTINAL INJURY 17 0.0063
385 PNEUMOCYSTIS JIROVECI PNEUMONIA 14 0.0063
386 BLOOD LACTATE DEHYDROGENASE INCREASED 98 0.0062
387 MULTIPLE-DRUG RESISTANCE 19 0.0061
388 GROWTH RETARDATION 18 0.0061
389 AORTIC VALVE INCOMPETENCE 26 0.0061
390 CARDIAC TAMPONADE 29 0.0061
391 EXOPHTHALMOS 13 0.0060
392 ORAL DISORDER 44 0.0060
393 NEUROTOXICITY 105 0.0060
394 LEUKAEMIA 56 0.0059
395 HAEMORRHAGE URINARY TRACT 15 0.0059
396 LYMPHOMA 91 0.0059
397 OSTEONECROSIS OF JAW 145 0.0059
398 ACTINIC KERATOSIS 15 0.0058
399 VASCULAR DEVICE INFECTION 26 0.0057
400 ORGANISING PNEUMONIA 28 0.0056
401 COVID-19 PNEUMONIA 66 0.0056
402 SUSPECTED OFF LABEL USE 25 0.0055
403 RESPIRATORY FAILURE 402 0.0055
404 HAEMODYNAMIC INSTABILITY 42 0.0055
405 GASTROINTESTINAL NECROSIS 16 0.0055
406 SKIN TOXICITY 31 0.0055
407 METASTASIS 39 0.0055
408 BRONCHIOLITIS 19 0.0054
409 FAILURE TO THRIVE 28 0.0054
410 LEUKOPENIA 269 0.0054
411 ENCEPHALOPATHY 132 0.0054
412 ACUTE RESPIRATORY FAILURE 103 0.0053
413 DRUG RESISTANCE 137 0.0053
414 COLITIS 201 0.0053
415 MALIGNANT MELANOMA 71 0.0053
416 PULMONARY HYPERTENSION 109 0.0052
417 STOMATITIS 317 0.0052
418 PNEUMONITIS 142 0.0052
419 RECURRENT CANCER 21 0.0051
420 PNEUMONIA BACTERIAL 47 0.0051
421 CLONUS 14 0.0051
422 CARDIAC FAILURE ACUTE 34 0.0051
423 PATHOGEN RESISTANCE 46 0.0050
424 COMPRESSION FRACTURE 27 0.0050
425 INFECTION 718 0.0050
426 NEPHROTIC SYNDROME 34 0.0050
427 RETINAL DETACHMENT 45 0.0049
428 CARDIOMEGALY 60 0.0049
429 PAPILLOEDEMA 22 0.0049
430 DISEASE RECURRENCE 230 0.0048
431 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 49 0.0048
432 TRANSPLANT REJECTION 38 0.0047
433 RESPIRATORY TRACT INFECTION 123 0.0047
434 HERPES VIRUS INFECTION 27 0.0047
435 HYPOXIA 165 0.0047
436 APLASIA PURE RED CELL 16 0.0046
437 CHEST X-RAY ABNORMAL 14 0.0046
438 BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0045
439 ATRIAL FLUTTER 36 0.0045
440 HERPES ZOSTER 259 0.0045
441 HEPATOTOXICITY 100 0.0045
442 CEREBRAL ISCHAEMIA 23 0.0045
443 HAEMOLYTIC ANAEMIA 40 0.0045
444 ILEUS 55 0.0044
445 TOOTH ABSCESS 45 0.0044
446 DEVICE RELATED INFECTION 68 0.0044
447 HEPATIC LESION 19 0.0044
448 ARTHRITIS BACTERIAL 18 0.0044
449 JAW DISORDER 24 0.0044
450 BRONCHOPNEUMONIA 15 0.0044
451 ATYPICAL PNEUMONIA 13 0.0043
452 LOOSE TOOTH 14 0.0043
453 GRANULOMA 15 0.0043
454 PLEURAL EFFUSION 263 0.0043
455 ASCITES 127 0.0043
456 ENDOCARDITIS 22 0.0043
457 ANGIOPATHY 24 0.0043
458 CEREBRAL ATROPHY 17 0.0043
459 PULMONARY ARTERIAL HYPERTENSION 61 0.0042
460 RESPIRATORY DISTRESS 116 0.0042
461 TOXIC SKIN ERUPTION 42 0.0042
462 MITRAL VALVE INCOMPETENCE 47 0.0041
463 SQUAMOUS CELL CARCINOMA 39 0.0041
464 STREPTOCOCCAL INFECTION 23 0.0041
465 EMBOLISM 34 0.0041
466 IMMUNE-MEDIATED ENTEROCOLITIS 15 0.0041
467 OLIGURIA 25 0.0040
468 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
469 HYPERNATRAEMIA 20 0.0040
470 PARTIAL SEIZURES 21 0.0040
471 STAPHYLOCOCCAL INFECTION 132 0.0040
472 AGRANULOCYTOSIS 74 0.0040
473 LEFT VENTRICULAR HYPERTROPHY 17 0.0040
474 TOXIC ENCEPHALOPATHY 20 0.0039
475 HYPOVOLAEMIA 23 0.0039
476 FUNGAL INFECTION 131 0.0039
477 RENAL FAILURE CHRONIC 30 0.0039
478 ADRENAL INSUFFICIENCY 47 0.0039
479 GINGIVAL SWELLING 17 0.0038
480 FLUID OVERLOAD 56 0.0038
481 PULSELESS ELECTRICAL ACTIVITY 16 0.0038
482 EXERCISE TOLERANCE DECREASED 22 0.0038
483 SPINAL COLUMN STENOSIS 18 0.0038
484 METABOLIC DISORDER 22 0.0038
485 HEPATIC FAILURE 114 0.0038
486 RENAL CYST 30 0.0038
487 TRICUSPID VALVE INCOMPETENCE 30 0.0038
488 NEUTROPHIL COUNT DECREASED 153 0.0038
489 SPINAL COMPRESSION FRACTURE 31 0.0037
490 PRODUCT USE IN UNAPPROVED INDICATION 929 0.0037
491 CANDIDIASIS 15 0.0037
492 BLOOD BILIRUBIN INCREASED 101 0.0037
493 HYPERTRANSAMINASAEMIA 26 0.0037
494 ACUTE KIDNEY INJURY 572 0.0037
495 DEEP VEIN THROMBOSIS 242 0.0037
496 BRONCHIECTASIS 25 0.0037
497 GINGIVITIS 20 0.0037
498 ODYNOPHAGIA 22 0.0037
499 DECUBITUS ULCER 30 0.0037
500 GASTROINTESTINAL INFECTION 33 0.0037
501 CONJUNCTIVAL HAEMORRHAGE 14 0.0037
502 PERIORBITAL OEDEMA 19 0.0037
503 ANAEMIA 693 0.0036
504 DISSEMINATED INTRAVASCULAR COAGULATION 51 0.0036
505 CLOSTRIDIUM DIFFICILE INFECTION 79 0.0036
506 SPINAL CORD COMPRESSION 14 0.0036
507 INTERVERTEBRAL DISC DEGENERATION 33 0.0036
508 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 21 0.0035
509 EJECTION FRACTION DECREASED 55 0.0035
510 INTENTIONAL PRODUCT USE ISSUE 310 0.0035
511 PNEUMOTHORAX 56 0.0035
512 AMYLASE INCREASED 13 0.0035
513 GUILLAIN-BARRE SYNDROME 17 0.0035
514 LUNG INFECTION 54 0.0035
515 HAEMODIALYSIS 29 0.0034
516 NEOPLASM PROGRESSION 120 0.0034
517 CARDIAC FAILURE 277 0.0034
518 INTESTINAL ISCHAEMIA 19 0.0034
519 DIVERTICULUM INTESTINAL 15 0.0034
520 PHYSICAL DISABILITY 15 0.0034
521 NO THERAPEUTIC RESPONSE 41 0.0034
522 HYPOCALCAEMIA 63 0.0033
523 PULMONARY OEDEMA 149 0.0033
524 TACHYPNOEA 45 0.0033
525 BUNDLE BRANCH BLOCK LEFT 14 0.0033
526 PNEUMONIA 1066 0.0033
527 BLOOD ALBUMIN DECREASED 26 0.0033
528 TOXICITY TO VARIOUS AGENTS 550 0.0033
529 TUBULOINTERSTITIAL NEPHRITIS 61 0.0033
530 MYOPATHY 28 0.0032
531 DERMATITIS EXFOLIATIVE 16 0.0032
532 RENAL FAILURE 424 0.0032
533 LYMPHADENOPATHY 113 0.0032
534 IMMUNOSUPPRESSION 28 0.0032
535 HYPOMAGNESAEMIA 44 0.0032
536 MENINGITIS 21 0.0031
537 PULMONARY CONGESTION 41 0.0031
538 DIVERTICULUM 22 0.0031
539 PYREXIA 1071 0.0031
540 RENAL FAILURE ACUTE 131 0.0031
541 BRONCHOSPASM 44 0.0031
542 HYPOKALAEMIA 142 0.0031
543 GENERALISED OEDEMA 38 0.0031
544 TRANSAMINASES INCREASED 68 0.0031
545 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 167 0.0030
546 PAIN IN JAW 86 0.0030
547 INTESTINAL PERFORATION 34 0.0030
548 ACUTE HEPATIC FAILURE 41 0.0030
549 BLOOD DISORDER 24 0.0030
550 RENAL IMPAIRMENT 250 0.0030
551 NEUROLOGICAL SYMPTOM 17 0.0030
552 ATRIAL FIBRILLATION 287 0.0029
553 GASTROENTERITIS 43 0.0029
554 VIRAL INFECTION 98 0.0029
555 EYELID OEDEMA 34 0.0029
556 HYPOVOLAEMIC SHOCK 14 0.0029
557 ECCHYMOSIS 20 0.0029
558 CACHEXIA 15 0.0029
559 COAGULOPATHY 48 0.0029
560 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
561 EYELID PTOSIS 29 0.0029
562 GLOMERULAR FILTRATION RATE DECREASED 35 0.0028
563 OFF LABEL USE 2484 0.0028
564 STATUS EPILEPTICUS 32 0.0028
565 DENTAL CARIES 31 0.0028
566 DRUG TOXICITY 38 0.0028
567 PARANOIA 48 0.0028
568 MALNUTRITION 31 0.0028
569 IMPAIRED HEALING 90 0.0027
570 EXOSTOSIS 25 0.0027
571 IMMUNE SYSTEM DISORDER 36 0.0027
572 PLATELET COUNT DECREASED 291 0.0027
573 HAEMOLYSIS 21 0.0027
574 OSTEOPENIA 41 0.0027
575 HUMERUS FRACTURE 13 0.0027
576 MALIGNANT NEOPLASM PROGRESSION 276 0.0027
577 EMPHYSEMA 27 0.0027
578 DEFORMITY 25 0.0027
579 RIB FRACTURE 55 0.0027
580 PULMONARY FIBROSIS 51 0.0027
581 ACUTE CORONARY SYNDROME 22 0.0027
582 SERUM FERRITIN INCREASED 14 0.0027
583 ORTHOSTATIC HYPOTENSION 46 0.0026
584 PULMONARY MASS 39 0.0026
585 HEPATITIS ACUTE 17 0.0026
586 ATAXIA 31 0.0026
587 LARGE INTESTINE PERFORATION 18 0.0026
588 HYPERGLYCAEMIA 94 0.0026
589 CARDIOGENIC SHOCK 37 0.0026
590 PROTEINURIA 49 0.0026
591 MASS 36 0.0026
592 RIGHT VENTRICULAR FAILURE 18 0.0026
593 RASH MACULO-PAPULAR 57 0.0026
594 ANURIA 22 0.0026
595 PYELONEPHRITIS 22 0.0025
596 SINUS TACHYCARDIA 36 0.0025
597 LUNG DISORDER 123 0.0025
598 PROTHROMBIN TIME PROLONGED 15 0.0025
599 ELECTROLYTE IMBALANCE 29 0.0025
600 ACUTE PULMONARY OEDEMA 14 0.0025
601 MENTAL STATUS CHANGES 69 0.0025
602 NERVOUS SYSTEM DISORDER 77 0.0025
603 JOINT EFFUSION 17 0.0025
604 NEPHROPATHY 23 0.0025
605 GRANULOCYTOPENIA 14 0.0025
606 ABSCESS 39 0.0024
607 TOXIC EPIDERMAL NECROLYSIS 37 0.0024
608 CEREBRAL DISORDER 18 0.0024
609 INTERSTITIAL LUNG DISEASE 117 0.0024
610 HYPERTRIGLYCERIDAEMIA 14 0.0024
611 GINGIVAL PAIN 19 0.0024
612 DECREASED INTEREST 14 0.0024
613 APPENDICITIS 22 0.0024
614 CHOLECYSTITIS 28 0.0023
615 CHOLESTASIS 45 0.0023
616 METASTASES TO LUNG 27 0.0023
617 HEPATITIS C 28 0.0023
618 SPLENOMEGALY 27 0.0023
619 SMALL INTESTINAL OBSTRUCTION 28 0.0023
620 UPPER RESPIRATORY TRACT INFECTION 105 0.0023
621 HYPONATRAEMIA 128 0.0023
622 THERAPY NON-RESPONDER 102 0.0023
623 HEPATITIS 58 0.0023
624 SCOLIOSIS 14 0.0023
625 DRUG ERUPTION 40 0.0023
626 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
627 MOUTH HAEMORRHAGE 16 0.0022
628 RENAL TUBULAR NECROSIS 21 0.0021
629 END STAGE RENAL DISEASE 39 0.0021
630 PULMONARY EMBOLISM 203 0.0021
631 ORAL CANDIDIASIS 28 0.0021
632 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
633 SKIN MASS 14 0.0021
634 HAEMORRHAGE INTRACRANIAL 31 0.0021
635 METASTASES TO BONE 34 0.0021
636 HICCUPS 17 0.0021
637 SINUS BRADYCARDIA 20 0.0021
638 LYMPHOEDEMA 14 0.0020
639 VENTRICULAR EXTRASYSTOLES 21 0.0020
640 PHARYNGITIS 25 0.0020
641 HYPERLIPIDAEMIA 24 0.0020
642 HIATUS HERNIA 26 0.0020
643 ANGINA UNSTABLE 13 0.0020
644 MOUTH ULCERATION 42 0.0020
645 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
646 SUDDEN DEATH 21 0.0020
647 ASPARTATE AMINOTRANSFERASE INCREASED 105 0.0020
648 BLOOD UREA INCREASED 33 0.0020
649 DEAFNESS 51 0.0019
650 ANOREXIA 25 0.0019
651 NEURALGIA 47 0.0019
652 TENDERNESS 20 0.0019
653 HAEMORRHOIDS 37 0.0019
654 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
655 HYDRONEPHROSIS 14 0.0019
656 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 133 0.0019
657 HAEMATURIA 64 0.0019
658 SUBARACHNOID HAEMORRHAGE 19 0.0019
659 GASTRITIS 49 0.0019
660 BLOOD CREATININE INCREASED 120 0.0018
661 INTERVERTEBRAL DISC PROTRUSION 40 0.0018
662 NEOPLASM 21 0.0018
663 PETECHIAE 19 0.0018
664 SUBDURAL HAEMATOMA 26 0.0018
665 HAEMATOCRIT DECREASED 36 0.0018
666 TRANSFUSION 19 0.0018
667 ARTERIOSCLEROSIS 17 0.0018
668 SPINAL DISORDER 17 0.0018
669 FISTULA 20 0.0018
670 GASTROINTESTINAL HAEMORRHAGE 148 0.0018
671 LEUKOCYTOSIS 32 0.0018
672 CELLULITIS 89 0.0018
673 OEDEMA 95 0.0017
674 JAUNDICE 47 0.0017
675 TOOTH INFECTION 23 0.0017
676 HEPATIC FUNCTION ABNORMAL 65 0.0017
677 PNEUMONIA ASPIRATION 43 0.0017
678 DISORIENTATION 68 0.0017
679 DIARRHOEA HAEMORRHAGIC 16 0.0017
680 ACIDOSIS 13 0.0017
681 PURPURA 15 0.0017
682 DIALYSIS 24 0.0017
683 APHTHOUS ULCER 13 0.0017
684 CEREBRAL HAEMORRHAGE 60 0.0017
685 BRAIN OEDEMA 21 0.0017
686 BONE PAIN 97 0.0017
687 PRODUCT USE ISSUE 310 0.0016
688 DELIRIUM 57 0.0016
689 UNEVALUABLE EVENT 124 0.0016
690 LIVER DISORDER 72 0.0016
691 C-REACTIVE PROTEIN INCREASED 59 0.0016
692 TACHYCARDIA 144 0.0016
693 HEPATIC ENCEPHALOPATHY 15 0.0016
694 GENERAL PHYSICAL HEALTH DETERIORATION 184 0.0016
695 MELAENA 35 0.0016
696 ARRHYTHMIA 75 0.0016
697 DERMATITIS 33 0.0016
698 DIARRHOEA 1016 0.0016
699 ORAL PAIN 35 0.0016
700 PANCREATITIS ACUTE 35 0.0016
701 GASTROINTESTINAL DISORDER 139 0.0016
702 TOOTH FRACTURE 17 0.0015
703 OPTIC NEURITIS 14 0.0015
704 HYPOTENSION 309 0.0015
705 ALANINE AMINOTRANSFERASE INCREASED 94 0.0015
706 HYPOPHAGIA 39 0.0015
707 SCAR 26 0.0015
708 WHITE BLOOD CELL COUNT DECREASED 164 0.0015
709 HYPERKALAEMIA 53 0.0015
710 CARDIAC MURMUR 13 0.0015
711 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
712 UPPER GASTROINTESTINAL HAEMORRHAGE 25 0.0015
713 BURSITIS 18 0.0015
714 MYOCARDITIS 17 0.0015
715 LYMPHOCYTE COUNT DECREASED 26 0.0015
716 HAEMATEMESIS 37 0.0015
717 ACUTE MYOCARDIAL INFARCTION 43 0.0015
718 OEDEMA PERIPHERAL 177 0.0015
719 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
720 HYPERCHOLESTEROLAEMIA 14 0.0014
721 LIVER FUNCTION TEST INCREASED 31 0.0014
722 HAEMOGLOBIN DECREASED 148 0.0014
723 STEVENS-JOHNSON SYNDROME 32 0.0014
724 TOOTHACHE 26 0.0014
725 METASTASES TO LIVER 25 0.0014
726 MUSCULOSKELETAL CHEST PAIN 22 0.0014
727 LOWER RESPIRATORY TRACT INFECTION 64 0.0014
728 HYPOTONIA 14 0.0014
729 TREATMENT FAILURE 116 0.0014
730 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
731 TOOTH LOSS 29 0.0014
732 HYPERTENSION 296 0.0014
733 VENTRICULAR TACHYCARDIA 23 0.0014
734 SHOCK 32 0.0014
735 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
736 RENAL DISORDER 64 0.0014
737 FACE OEDEMA 23 0.0014
738 DYSURIA 50 0.0014
739 TOOTH DISORDER 30 0.0013
740 THYROID CANCER 16 0.0013
741 SKIN DISORDER 44 0.0013
742 MYOCARDIAL ISCHAEMIA 15 0.0013
743 OSTEOPOROSIS 54 0.0013
744 ABNORMAL BEHAVIOUR 52 0.0013
745 EPILEPSY 40 0.0013
746 DYSPNOEA EXERTIONAL 49 0.0013
747 OSTEOARTHRITIS 55 0.0013
748 ASPIRATION 14 0.0013
749 RED BLOOD CELL COUNT DECREASED 36 0.0013
750 INFUSION RELATED REACTION 83 0.0013
751 PERICARDITIS 21 0.0012
752 SKIN INFECTION 14 0.0012
753 CARDIAC ARREST 103 0.0012
754 CARDIAC FAILURE CONGESTIVE 100 0.0012
755 SKIN LESION 34 0.0012
756 RESPIRATORY DISORDER 37 0.0012
757 ISCHAEMIC STROKE 22 0.0012
758 URINARY RETENTION 41 0.0012
759 BRADYCARDIA 65 0.0012
760 HYPOTHYROIDISM 39 0.0012
761 THERAPEUTIC RESPONSE DECREASED 73 0.0012
762 SPINAL PAIN 14 0.0012
763 THROMBOSIS 96 0.0012
764 CEREBRAL INFARCTION 29 0.0012
765 LIVER INJURY 29 0.0012
766 CIRCULATORY COLLAPSE 20 0.0012
767 MYOCLONUS 14 0.0012
768 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
769 PERITONITIS 24 0.0012
770 COVID-19 202 0.0012
771 GASTRIC CANCER 29 0.0011
772 COLON CANCER 17 0.0011
773 CONJUNCTIVITIS 21 0.0011
774 HEPATIC STEATOSIS 21 0.0011
775 BODY TEMPERATURE INCREASED 23 0.0011
776 BRONCHITIS 83 0.0011
777 INTESTINAL OBSTRUCTION 42 0.0011
778 CATARACT 66 0.0011
779 CARDIOVASCULAR DISORDER 28 0.0011
780 CYSTITIS 35 0.0011
781 CONFUSIONAL STATE 177 0.0011
782 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
783 DEHYDRATION 145 0.0011
784 DIVERTICULITIS 30 0.0011
785 HAEMOPTYSIS 30 0.0011
786 EPISTAXIS 80 0.0011
787 ULCER 17 0.0011
788 CHOLELITHIASIS 35 0.0011
789 INFLAMMATION 55 0.0011
790 SKIN REACTION 15 0.0011
791 DRUG INEFFECTIVE 1400 0.0011
792 URINARY TRACT INFECTION 181 0.0011
793 PARALYSIS 15 0.0010
794 MUSCULAR WEAKNESS 119 0.0010
795 PRESYNCOPE 25 0.0010
796 ORAL HERPES 20 0.0010
797 DRUG INTOLERANCE 97 0.0010
798 FRACTURE 19 0.0010
799 HEMIPARESIS 17 0.0010
800 DRUG EFFECT INCOMPLETE 36 0.0010
801 DRUG-INDUCED LIVER INJURY 31 0.0010
802 GLAUCOMA 19 0.0010
803 AMENORRHOEA 17 0.0010
804 METABOLIC ACIDOSIS 31 0.0010
805 HAEMATOMA 25 0.0010
806 CONVULSION 55 0.0010
807 SYNCOPE 96 0.0010
808 CORONARY ARTERY DISEASE 29 0.0010
809 VOMITING 444 0.0009
810 FULL BLOOD COUNT DECREASED 19 0.0009
811 HALLUCINATION 70 0.0009
812 HAEMORRHAGE 96 0.0009
813 DYSPHAGIA 87 0.0009
814 ANHEDONIA 24 0.0009
815 DECREASED APPETITE 212 0.0009
816 AGITATION 67 0.0009
817 URINARY INCONTINENCE 27 0.0009
818 EAR INFECTION 24 0.0009
819 WOUND 25 0.0009
820 ABDOMINAL PAIN 206 0.0009
821 POST PROCEDURAL COMPLICATION 17 0.0009
822 CARDIO-RESPIRATORY ARREST 37 0.0009
823 INFLUENZA 97 0.0009
824 NIGHT SWEATS 28 0.0009
825 POLLAKIURIA 36 0.0009
826 RECTAL HAEMORRHAGE 37 0.0009
827 LOCAL SWELLING 15 0.0009
828 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
829 PRODUCTIVE COUGH 41 0.0009
830 ANAPHYLACTIC SHOCK 22 0.0009
831 CHILLS 99 0.0008
832 CONSTIPATION 184 0.0008
833 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 44 0.0008
834 VISUAL ACUITY REDUCED 28 0.0008
835 CHRONIC KIDNEY DISEASE 64 0.0008
836 FEMUR FRACTURE 26 0.0008
837 INJURY 59 0.0008
838 SINUSITIS 86 0.0008
839 RASH ERYTHEMATOUS 40 0.0008
840 GASTROENTERITIS VIRAL 15 0.0008
841 RASH 358 0.0008
842 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
843 CARDIAC DISORDER 76 0.0008
844 SINUS DISORDER 16 0.0008
845 FLUID RETENTION 41 0.0008
846 MUSCULOSKELETAL PAIN 42 0.0008
847 DIABETES MELLITUS 61 0.0008
848 COMA 38 0.0008
849 COUGH 223 0.0008
850 APHASIA 24 0.0008
851 HYPOAESTHESIA 118 0.0008
852 ANGINA PECTORIS 22 0.0008
853 BLINDNESS 31 0.0008
854 DISTURBANCE IN ATTENTION 41 0.0008
855 PANCREATITIS 40 0.0008
856 LACTIC ACIDOSIS 24 0.0007
857 UNRESPONSIVE TO STIMULI 19 0.0007
858 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
859 DEATH 632 0.0007
860 DIPLOPIA 19 0.0007
861 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
862 GOUT 13 0.0007
863 EAR PAIN 14 0.0007
864 NAUSEA 559 0.0007
865 ERECTILE DYSFUNCTION 18 0.0007
866 DYSPNOEA 396 0.0007
867 SKIN ULCER 18 0.0007
868 SEIZURE 80 0.0007
869 ASTHENIA 260 0.0007
870 ERYTHEMA 141 0.0007
871 RENAL INJURY 20 0.0007
872 ADVERSE EVENT 62 0.0007
873 BLOOD POTASSIUM DECREASED 20 0.0007
874 SWELLING 62 0.0007
875 LETHARGY 38 0.0007
876 CONDITION AGGRAVATED 200 0.0007
877 LIVER FUNCTION TEST ABNORMAL 19 0.0007
878 ILL-DEFINED DISORDER 39 0.0006
879 ABDOMINAL DISTENSION 67 0.0006
880 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
881 HAEMATOCHEZIA 35 0.0006
882 PROSTATE CANCER 51 0.0006
883 MEDICATION ERROR 35 0.0006
884 OXYGEN SATURATION DECREASED 35 0.0006
885 BACK PAIN 144 0.0006
886 INTENTIONAL PRODUCT MISUSE 54 0.0006
887 NEOPLASM MALIGNANT 41 0.0006
888 HYPOGLYCAEMIA 29 0.0006
889 EMOTIONAL DISTRESS 71 0.0006
890 PARAESTHESIA 92 0.0006
891 WEIGHT DECREASED 163 0.0006
892 HIP FRACTURE 18 0.0006
893 ARTHROPATHY 31 0.0006
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
895 RESPIRATORY ARREST 15 0.0005
896 TINNITUS 25 0.0005
897 HEPATIC ENZYME INCREASED 37 0.0005
898 DEMENTIA 15 0.0005
899 HYPOACUSIS 23 0.0005
900 DRUG INTERACTION 84 0.0005
901 WHEEZING 31 0.0005
902 OROPHARYNGEAL PAIN 48 0.0005
903 FATIGUE 401 0.0005
904 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
905 ARTHRITIS 39 0.0005
906 LUNG NEOPLASM MALIGNANT 20 0.0005
907 DYSGEUSIA 36 0.0005
908 DYSARTHRIA 18 0.0005
909 DISCOMFORT 29 0.0005
910 ANAPHYLACTIC REACTION 26 0.0005
911 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
912 PREMATURE BABY 14 0.0005
913 NEPHROLITHIASIS 21 0.0005
914 DYSPEPSIA 44 0.0004
915 GAIT DISTURBANCE 85 0.0004
916 DRUG ADMINISTRATION ERROR 13 0.0004
917 TREATMENT NONCOMPLIANCE 23 0.0004
918 TREMOR 68 0.0004
919 DRUG ABUSE 34 0.0004
920 COGNITIVE DISORDER 19 0.0004
921 CHEST PAIN 75 0.0004
922 FALL 134 0.0004
923 PAIN 247 0.0004
924 RASH MACULAR 14 0.0004
925 AMNESIA 26 0.0004
926 MYOCARDIAL INFARCTION 67 0.0004
927 RHABDOMYOLYSIS 16 0.0004
928 WEIGHT INCREASED 85 0.0004
929 ADVERSE DRUG REACTION 34 0.0004
930 BLOOD PRESSURE DECREASED 25 0.0004
931 BREAST CANCER 35 0.0004
932 NASAL CONGESTION 22 0.0004
933 BLISTER 21 0.0004
934 PAIN IN EXTREMITY 110 0.0004
935 ANXIETY 105 0.0004
936 MENTAL DISORDER 16 0.0004
937 NECK PAIN 20 0.0004
938 MULTIPLE SCLEROSIS 17 0.0004
939 CEREBROVASCULAR ACCIDENT 60 0.0004
940 CHEST DISCOMFORT 36 0.0004
941 DRY MOUTH 28 0.0003
942 HYPERSENSITIVITY 64 0.0003
943 SKIN EXFOLIATION 29 0.0003
944 INSOMNIA 91 0.0003
945 CONTUSION 32 0.0003
946 RHINORRHOEA 21 0.0003
947 HEART RATE INCREASED 32 0.0003
948 BLADDER CANCER 19 0.0003
949 DEPRESSION 72 0.0003
950 OCULAR HYPERAEMIA 15 0.0003
951 LOSS OF CONSCIOUSNESS 40 0.0003
952 DIZZINESS 154 0.0003
953 DRY EYE 15 0.0003
954 VISION BLURRED 41 0.0003
955 SOMNOLENCE 59 0.0003
956 SWELLING FACE 19 0.0003
957 SUICIDAL IDEATION 26 0.0003
958 VERTIGO 17 0.0003
959 MOBILITY DECREASED 20 0.0003
960 MUSCLE SPASMS 50 0.0003
961 MYALGIA 46 0.0003
962 ARTHRALGIA 109 0.0003
963 VISUAL IMPAIRMENT 32 0.0003
964 DYSPHONIA 15 0.0003
965 SLEEP DISORDER 18 0.0003
966 ABDOMINAL PAIN UPPER 52 0.0003
967 INJECTION SITE REACTION 17 0.0002
968 ALOPECIA 47 0.0002
969 BURNING SENSATION 16 0.0002
970 FLUSHING 23 0.0002
971 DRY SKIN 30 0.0002
972 PRURITUS 81 0.0002
973 HEADACHE 130 0.0002
974 INFLUENZA LIKE ILLNESS 17 0.0002
975 NO ADVERSE EVENT 35 0.0002
976 BLOOD PRESSURE INCREASED 29 0.0002
977 JOINT SWELLING 22 0.0002
978 ASTHMA 20 0.0002
979 HYPERHIDROSIS 22 0.0002
980 PALPITATIONS 20 0.0002
981 HOSPITALISATION 26 0.0002
982 ABDOMINAL DISCOMFORT 28 0.0002
983 MEMORY IMPAIRMENT 20 0.0001
984 PERIPHERAL SWELLING 22 0.0001
985 MALAISE 58 0.0001
986 URTICARIA 22 0.0001
987 BLOOD GLUCOSE INCREASED 24 0.0001
988 PSORIASIS 16 0.0001
989 NASOPHARYNGITIS 22 0.0001
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
991 OVERDOSE 17 0.0001